Clinical Trial Update: Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 safety and immunogenicity study of a tuberculosis vaccine candidate in healthy infants completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GSK tuberculosis vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2018-11-27